Acquired alterations in mitochondrial DNA are believed to play a pathogenic role in Parkinson's disease. In particular, accumulation of mitochondrial DNA deletions has been observed in substantia nigra pars compacta dopaminergic neurons from patients with Parkinson's disease and aged individuals. Also, mutations in mitochondrial DNA polymerase gamma result in multiple mitochondrial DNA deletions that can be associated with levodopa-responsive parkinsonism and severe substantia nigra pars compacta dopaminergic neurodegeneration. However, whether mitochondrial DNA deletions play a causative role in the demise of dopaminergic neurons remains unknown. Here we assessed the potential pathogenic effects of mitochondrial DNA deletions on the dopaminergic nigrostriatal system by using mutant mice possessing a proofreadingdeficient form of mitochondrial DNA polymerase gamma (POLG D257A ), which results in a time-dependent accumulation of mitochondrial DNA deletions in several tissues, including the brain. In these animals, we assessed the occurrence of mitochondrial DNA deletions within individual substantia nigra pars compacta dopaminergic neurons, by laser capture microdissection and quantitative real-time polymerase chain reaction, and determined the potential deleterious effects of such mitochondrial DNA alterations on mitochondrial function and dopaminergic neuronal integrity, by cytochrome c oxidase histochemistry and quantitative morphology. Nigral dopaminergic neurons from POLG D257A mice accumulate mitochondrial DNA deletions to a similar extent ($40-60%) as patients with Parkinson's disease and aged individuals. Despite such high levels of mitochondrial DNA deletions, the majority of substantia nigra pars compacta dopaminergic neurons from doi:10.1093/brain/awt196 these animals did not exhibit mitochondrial dysfunction or degeneration. Only a few individual substantia nigra pars compacta neurons appeared as cytochrome c oxidase-negative, which exhibited higher levels of mitochondrial DNA deletions than cytochrome c oxidase-positive cells (60.38 AE 3.92% versus 45.18 AE 2.83%). Survival of dopaminergic neurons in POLG D257A mice was associated with increased mitochondrial DNA copy number, enhanced mitochondrial cristae network, improved mitochondrial respiration, decreased exacerbation of mitochondria-derived reactive oxygen species, greater striatal dopamine levels and resistance to parkinsonian mitochondrial neurotoxins. These results indicate that primary accumulation of mitochondrial DNA deletions within substantia nigra pars compacta dopaminergic neurons, at an extent similar to that observed in patients with Parkinson's disease, do not kill dopaminergic neurons but trigger neuroprotective compensatory mechanisms at a mitochondrial level that may account for the high pathogenic threshold of mitochondrial DNA deletions in these cells.
Introduction
Alterations in mitochondrial DNA have long been hypothesized to play a pathogenic role in Parkinson's disease. In particular, multiple mitochondrial DNA deletions have been observed in substantia nigra pars compacta dopaminergic neurons from post-mortem human brains of both aged individuals and patients with idiopathic Parkinson's disease (Bender et al., 2006; Kraytsberg et al., 2006) . Also, mutations in mitochondrial DNA polymerase gamma (POLG), which result in the accumulation of multiple mitochondrial DNA deletions in muscle, have been associated with levodopa-responsive parkinsonism with severe substantia nigra pars compacta dopaminergic neuronal loss, usually as part of a more complex syndrome (Luoma et al., 2004; Davidzon et al., 2006) . In addition, a major theory of ageing, which is the most consistent risk factor for developing Parkinson's disease, postulates that a lifelong accumulation of mitochondrial DNA alterations, especially deletions, in multiple tissues eventually results in mitochondrial failure and subsequent age-related decline in tissue function (Wallace, 2005) . Taken together, these observations raise the possibility that progressive accumulation of mitochondrial DNA deletions acquired during ageing may contribute to the pathogenesis of Parkinson's disease.
To address this question, we assessed the potential pathogenic effects of mitochondrial DNA deletions on the dopaminergic nigrostriatal system by using mutant mice possessing an amino acid substitution (D257A) in the exonuclease domain II of POLG that ablates its proofreading activity without significantly affecting the capacity of the polymerase to replicate mitochondrial DNA (Trifunovic et al., 2004; Kujoth et al., 2005) . Homozygous POLG D257A mice accumulate mitochondrial DNA deletions in several tissues, including the brain (Vermulst et al., 2008) , and exhibit features of accelerated ageing, increased apoptosis in non-neuronal tissues and reduced lifespan (i.e. the animals die prematurely, by 13 months of age) (Kujoth et al., 2005) . In these animals, we first assessed the occurrence of mitochondrial DNA deletions in substantia nigra pars compacta dopaminergic neurons at the single cell level and then explored the potential pathogenic consequences of such mitochondrial DNA alterations on the nigrostriatal dopaminergic system.
Materials and methods

Animals and treatments
C57Bl/6J mice heterozygous for POLG were mated to yield F1 offspring with wild-type ( + / + ), D257A heterozygous (D257A/ + ), and D257A homozygous (D257A/D257A) mice. For the different analyses reported here, 6-to 13-month-old wild-type or POLG D257A mutant mice have been used (these mice have a reduced life span with a maximum survival of 460 days and a median survival of 416 days) (Kujoth et al., 2005) . For intoxication experiments, mice received one intraperitoneal injection of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-HCl per day (20 mg/kg per day of free base; SigmaAldrich) for five consecutive days and were sacrificed at 21 days after the last injection; control mice received saline injections only.
Tissue processing, histology and laser capture microdissection
Laser capture microdissection was performed using a Leica LMD 6000 microdissection system on either nigral tyrosine hydroxylase-positive cells or on cells sequentially stained for the histochemical activities of cytochrome c oxidase (COX) and succinate dehydrogenase, as previously described (Elstner et al., 2011 
Long-range polymerase chain reaction
To detect a large variety of large-scale mitochondrial DNA deletions, we designed a set of PCR primers that span the complete mitochondrial DNA molecule. Primers included M13 tails (forward M13-tail: TGTAAAACGACGGCCAGT; reverse M13-tail: CAGGAAACAGCTAT GACC) to facilitate easy sequencing of the PCR products with standard sequencing primers. A long-range PCR strategy (Expand Long Template PCR System Õ , Roche) was used to amplify $14 kb fragments with different forward and reverse primers, thus spanning the whole genome. PCR reactions used 25 ng of DNA as template and comprised 1 Â reaction buffer (Roche), 10 mM each dNTP, 10 mg bovine serum albumin (10Â ), 0.75 ml enzyme mix and 30 pmol of primers in a total volume of 50 ml. Amplifications were carried out using a GeneAmp Amplified products were separated through 0.8% agarose gels containing ethidium bromide and visualized over UV light.
Real-time polymerase chain reaction assay for mitochondrial DNA deletions and mitochondrial DNA copy number
The real-time PCR assay for mitochondrial DNA deletion quantification was based on the relative ND1/ND4-quantification method previously reported for human samples (Krishnan et al., 2007) For mitochondrial DNA copy number analysis, genomic DNA of a nuclear housekeeping gene [actin beta (ACTB), Applied Biosystems Endogenous Gene Expression Control] or ANG1 was also quantified using the same amount of DNA input. All deletions levels were normalized to mouse blood, which does not contain significant amounts of mitochondrial DNA deletions. To calculate deletion levels, all possible combinations of gene ratios (ND1/CytB; ND1/COX3; CytB/ COX3; CytB/ND1; COX3/ND1; COX3/CytB) were calculated and the maximum deletion levels were noted. Relative mitochondrial DNA copy number was determined by comparing the highest quantity of the three mitochondrial DNA genes to the nuclear endogenous control gene, also normalized to genomic DNA from blood.
Quantitative morphology
Assessment of nigrostriatal integrity was performed in brain tissue sections immunostained with a polyclonal anti-TH antibody (1:1000; Calbiochem). Sections were counterstained with Nissl. Total number of tyrosine hydroxylase-positive substantia nigra pars compacta neurons was assessed in the different groups of animals by using the optical fractionator method as previously described (Liberatore et al., 1999) . Optical densitometry of striatal tyrosine hydroxylase-positive terminals was determined using Scion Image software. Striatal levels of dopamine, serotonin (5-HT), 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) were measured by high-performance liquid chromatography with electrochemical detection (Sathe et al., 2012) .
Isolated brain mitochondria
To obtain non-synaptosomal total brain mitochondria, brains from 11-month-old wild-type ( + / + ) and D257A homozygous (D257A/ D257A) mice were homogenized in isolation buffer and centrifuged at 1000g for 10 min. The resulting supernatant was layered onto a gradient of Ficoll and centrifuged at 79 000g for 30 min. The mitochondrial pellet was resuspended in isolation buffer. For polarography studies in isolated brain mitochondria, oxygen consumption was monitored using a Clark-type electrode (Hansatech Instruments, PP System). To assess mitochondrial respiration mediated through complex I, mitochondria was pre-incubated with 10 mM glutamate and 5 mM malate in the absence or presence of 1-methyl-4-phenylpyridinium (MPP + , MPTP's active metabolite) for 5 min before 500 mM ADP was added to induce state 3 respiration (Perier et al., 2005) . For measurements of mitochondrial hydrogen peroxide (H 2 O 2 ) production, samples were prepared under conditions identical to those of polarographical study. H 2 O 2 converted from superoxide by manganese-superoxide dismutase was measured using 5 mM Amplex Õ red and 5 U/ml horseradish peroxidase. Fluorescence was detected with an excitation wavelength of 550 nm (slit 1.5 nm) and an emission wavelength of 585 nm (slit 3 nm). H 2 O 2 production was calculated from a standard curve generated from known concentrations of H 2 O 2 (Perier et al., 2005) . Mitochondrial membrane potential (Ácm) was measured with safranine, a cationic fluorescence dye that is accumulated and quenched inside energized mitochondria, as previously described (Perier et al., 2005) . Activity of mitochondrial complex I was measured as in Tieu et al., (2003) . Density of mitochondria cristae network was assessed in electron microscopy images of mitochondria uniformly selected at random among the different groups of animals using ImageJ software, as previously validated (Ramonet et al., 2013) .
Western blot
Protein ( 
Statistical analysis
All values are expressed as the mean AE SEM. Differences among means were analysed by using one-or two-way ANOVA. When ANOVA showed significant differences, pair-wise comparisons between means were tested by Student-Newman-Keuls post hoc testing. In all analyses, the null hypothesis was rejected at the 0.05 level. Correlations were calculated by means of Pearson's correlation coefficient.
Results
Accumulation of mitochondrial DNA deletions in substantia nigra pars compacta dopaminergic neurons of POLG D257A mice
Before exploring the potential pathogenic effects of mitochondrial DNA deletions on the nigrostriatal system, we confirmed first that POLG D257A mice did indeed accumulate mitochondrial DNA deletions within substantia nigra pars compacta dopaminergic neurons. The presence of mitochondrial DNA deletions was assessed by quantitative real-time PCR in different brain regions of 1-yearold POLG D257A mice. In these animals, a significant accumulation of mitochondrial DNA deletions was observed in ventral midbrain (which contains the substantia nigra pars compacta), striatum, cerebellum and cortex brain homogenates (Fig. 1A ). Among these regions, the striatum exhibited the highest accumulation of mitochondrial DNA deletions (10.68 AE 6.44% in wild-type animals , P 5 0.01). The presence of mitochondrial DNA deletions in the nigrostriatal system was further confirmed by long-range PCR, which showed midbrain and striatum homogenates from POLG D257A mice exhibited clonal expansion of deleted mitochondrial DNA species of different sizes that were absent in wild-type and heterozygous mouse littermates (Fig. 1B) .
To restrict the analysis of mitochondrial DNA deletions more specifically to the substantia nigra pars compacta, where Parkinson's disease-vulnerable dopaminergic neurons reside, we performed laser capture microdissection of the tyrosine hydroxylase-positive substantia nigra pars compacta area of the ventral midbrain, enriched in dopaminergic neurons, followed by quantitative real-time PCR (Fig. 2A) . This approach confirmed the wide accumulation of mitochondrial DNA deletions in this particular region (19.71 AE 1.21% in substantia nigra pars compacta of wild-type animals versus 52.55 AE 3.45% in substantia nigra pars compacta of POLG D257A mice, P 5 0.01) ( Fig. 2A) . To determine whether such high levels of mitochondrial DNA deletions resulted in mitochondrial respiratory chain defects, we performed dual histochemical analyses of both cytochrome c oxidase (COX) and succinate dehydrogenase in frozen midbrain sections from wildtype and POLG D257A mice. Using this technique, COX-negative cells can be identified by the nitrotetrazolium blue product in their cytoplasm (Fig. 2B ). Despite the overall high amount of mitochondrial DNA deletions observed in the substantia nigra pars compacta, only 1-3% of substantia nigra pars compacta neurons appeared as COX-negative, in agreement with previous observations in post-mortem substantia nigra pars compacta tissue from patients with Parkinson's disease (Bender et al., 2006) . Single-cell laser microdissection of either COX-positive (n = 40) or COXnegative (n = 37) neurons in the substantia nigra pars compacta revealed that COX-negative cells exhibited significantly higher levels of mitochondrial DNA deletions (60. To determine whether accumulation of mitochondrial DNA deletions may play a primary deleterious role on substantia nigra pars compacta dopaminergic neurons, we assessed the integrity of the dopaminergic nigrostriatal system in POLG D257A mice, up to 13 months (at which age they prematurely die). Compared to wild-type littermates, POLG D257A mice did not exhibit any degeneration of the nigrostriatal dopaminergic system at any age, as indicated by (i) unaffected number of substantia nigra pars compacta dopaminergic neurons (Fig. 3A) ; and (ii) unchanged density of striatal tyrosine hydroxylase-positive fibres (Fig. 3B) . Strikingly, striatal dopaminergic fibre density was not only decreased in POLG D257A mice compared to wild-type animals but it actually showed a trend towards increase (Fig. 3B) . Consistent with the . In both A and B, n = 5 for POLG D257A at 6 months, n = 8 for POLG D257A at 13 months, n = 8 for wild-type mice at 6 months, n = 11 for wild-type mice at 13 months. (C) High-performance liquid chromatography measurements of striatal levels of dopamine (DA), serotonin (5-HT), 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) in 1-year-old POLG D257A (n = 7) and wild-type (n = 11) mice. (D) Number of substantia nigra pars compacta tyrosine hydroxylase-positive neurons, as assessed by stereology, and density of striatal tyrosine hydroxylase-positive fibres, as assessed by optical densitometry, in 10-to 12-month-old POLG D257A and wild-type mice treated with either saline or MPTP (one intraperitoneal injection of 20 mg/kg/day MPTP for five consecutive days) and sacrificed 21 days after the last injection (n = 5 for the wild-type saline group, n = 10 for the POLG D257A saline group, n = 12 for the wild-type MPTP group and n = 11 for the POLG D257A MPTP group). Photomicrographs correspond to representative images of tyrosine hydroxylase-immunostained substantia nigra pars compacta (counterstained with thionin) and striatum in the different groups of animals, as indicated. In all panels, histograms represent average AE SEM. *P 5 0.05 compared with respective controls; # P 5 0.05 compared with MPTP wild-type mice. Scale bars = 500 mm.
latter, striatal levels of dopamine, but not of their metabolites (DOPAC, HVA) or other neurotransmitters such as serotonin, were increased in 1-year-old POLG D257A mice in comparison with wild-type animals, as revealed by high-performance liquid chromatography analyses (Fig. 3C ). The ratio (DOPAC + HVA)/ DA was diminished in POLG D257A mice, indicating decreased dopamine (DA) turnover in these animals (0.71 AE 0.12 in wildtype mice, 0.23 AE 0.10 in POLG D257A mice, P = 0.05).
Although the integrity of the nigrostriatal dopaminergic system was not affected per se in POLG D257A mice, we next determined whether accumulation of mitochondrial DNA deletions may increase the susceptibility of substantia nigra pars compacta dopaminergic neurons to parkinsonian mitochondrial neurotoxins, such as MPTP. As we were expecting an increased susceptibility of POLG D257A mice to MPTP-induced dopaminergic neurodegeneration, POLG D257A and wild-type mice (9 -to 13-monthsold) were treated with a particular regimen of MPTP (20 mg/kg/day for five consecutive days) that normally induces a mild ($20%) dopaminergic cell loss in regular wild-type animals ( Fig. 3D) . Surprisingly, POLG D257A mice were more resistant to MPTP-induced dopaminergic cell loss (Fig. 3D ). This protective effect at the level of substantia nigra pars compacta dopaminergic cell bodies was not extended, however, at the level of striatal dopaminergic fibres, which were similarly affected by MPTP in both wild-type and POLG D257A mice (Fig. 3D) .
Our results indicate that accumulation of mitochondrial DNA deletions in substantia nigra pars compacta dopaminergic neurons, to an extent similar to that observed in patients with Parkinson's disease and aged individuals, is not sufficient to trigger Parkinson's disease-like neurodegeneration in POLG D257A mice, neither by itself or by potentially increasing the susceptibility of these cells to parkinsonian mitochondrial neurotoxins. Instead, these animals exhibit increased striatal dopamine levels and are more resistant to MPTP-induced dopaminergic cell loss.
Mitochondrial DNA deletions trigger compensatory enhancement of mitochondrial function
To understand the lack of pathogenic effects of mitochondrial DNA deletions on the nigrostriatal system of POLG D257A mice, additional analyses were performed in isolated non-synaptosomal brain mitochondria derived from 11-to 13-month-old POLG D257A or wildtype mice. Despite exhibiting high levels of mitochondrial DNA deletions, basal complex I-driven mitochondrial respiration, as assessed by using polarography, was greater in POLG D257A -derived than wild-type-derived brain mitochondria (Fig. 4A) . However, when challenged by parkinsonian complex I inhibitors, such as MPP + , complex I-driven respiration was similarly affected in brain mitochondria from either POLG D257A or wild-type mice (Fig. 4A) .
Moreover, no differences between genotypes were observed for basal complex I activity measured by spectrophotometry either in the ventral midbrain ( AFUs; P 4 0.05; n = 3 animals per group). We then analysed mitochondrial production of reactive oxygen species by measuring H 2 O 2 in isolated brain mitochondria using the fluorescent dye Amplex red. At basal levels, we did not observe any differences in mitochondrial Figure 4 Enhanced mitochondrial function in the brain of POLG D257A mice. (A) Complex I-driven oxygen consumption in nonsynaptosomal brain mitochondrial from 11-to 13-month-old POLG D257A (n = 6) or wild-type (n = 6) mice. ADP-induced state 3 respiration was monitored using a Clark-type electrode in the presence or the absence of parkinsonian complex I inhibitor MPP + .
(B) Mitochondrial hydrogen peroxide (H 2 O 2 ) production in non-synaptosomal brain mitochondrial from 11-to 13-month-old POLG
D257A
(n = 6) or wild-type (n = 6) mice measured by spectrofluorimetry using the fluorescent dye Amplex Õ red in the presence or the absence of parkinsonian complex I inhibitors MPP + or rotenone. wt = wild-type.
reactive oxygen species production between POLG D257A -or wildtype-derived brain mitochondria (Fig. 4B) . However, when treated with parkinsonian complex I inhibitors MPP + or rotenone, which are known to exacerbate mitochondrial reactive oxygen species production (Perier et al., 2005) , POLG D257A -derived brain mitochondria exhibited reduced reactive oxygen species production compared with wild-type-derived mitochondria (Fig. 4B) . Further analyses by real-time PCR with mitochondrial and nuclear probes revealed that mitochondrial DNA copy number was increased in the ventral midbrain of POLG D257A mice compared with their wild-type counterparts (Fig. 5A) . In these animals, the number of mitochondrial DNA molecules positively correlated with the level of mitochondrial DNA deletions (Pearson's correlation coefficient r = 0.865; P 5 0.001; Fig. 5B ). In contrast, increased mitochondrial DNA copy number in POLG D257A mice was not associated with increased mitochondrial mass, as indicated by unchanged immunoblot levels of mitochondrial constituent protein VDAC in ventral midbrain total protein homogenates from wild-type and POLG D257A mice (Fig. 6A) . These results indicate that increased mitochondrial DNA copy number in POLG D257A mice does not Figure 6 Brain mitochondria morphology of POLG D257A mice. (A) Immunoblot levels of mitochondrial constituent protein VDAC in total protein homogenates from the midbrain region of 11-to 13-month-old wild-type (n = 9) and POLG D257A (n = 7) mice. (B) Immunoblot levels of OPA1, Mfn1 and Mfn2 in total protein homogenates from the midbrain region of 11-to 13-month-old wild-type (n = 9) and POLG D257A (n = 7) mice. (C) Quantification of electron density contributed by cristae within individual mitochondria derived from 11-to 13-month-old POLG D257A and wild-type mice. A total of 90 mitochondria were analysed uniformly, selected at random among the different groups of animals. Scale bars = 0.2 mm. In all panels, histograms represent average AE SEM. *P 5 0.05 compared with respective controls. correspond to an increased number of mitochondria in these animals but may result instead from an increased number of mitochondrial DNA molecules per mitochondria. Because the latter is compatible with increased mitochondrial fusion, we then compared the levels of mitochondrial pro-fusion proteins mitofusin 1 and 2 (MFN1, MFN2) and optic atrophy protein 1 (OPA1) in ventral midbrain total protein homogenates from POLG D257A and wild-type mice (Fig. 6B) . Although OPA1 immunoblot levels were increased in POLG D257A mice, mitofusin levels remained unchanged in these animals (Fig. 6B) . OPA1 is also known to maintain the integrity of mitochondria, independently of mitochondrial fusion, by keeping cristae junctions tight (Frezza et al., 2006) . Therefore, we next examined by electron microscopy the ultrastructure of isolated brain mitochondria from both POLG D257A and wild-type mice and quantified the density of cristae within individual mitochondria (Fig.  6C) . Consistent with the observed higher levels of OPA1, brain mitochondria from POLG D257A mice exhibited a much denser cristae network than their wild-type counterparts (Fig. 6C) . Together, these results indicate that accumulation of mitochondrial DNA deletions below a certain threshold can be overcome in affected cells by compensatory mechanisms at the level of mitochondria, including increased mitochondrial DNA copy number, enhanced cristae network and overall improvement of mitochondrial respiration.
Discussion
Here we show that substantia nigra pars compacta dopaminergic neurons can endure high levels of mitochondrial DNA deletions (up to 60%) without widespread functional or structural impairment. Such resistance results from compensatory gain-of-function mechanisms at the level of mitochondria, including increased mitochondrial DNA copy number and OPA1-related enhancement of mitochondrial cristae network, which leads to an overall improvement of mitochondrial respiration and decreased exacerbation of mitochondrial-derived reactive oxygen species production. As a consequence, nigrostriatal dopaminergic neurons with a high mitochondrial DNA deletion load not only do not degenerate but also exhibit higher dopamine levels and are less susceptible to parkinsonian neurotoxins such as MPTP. Toxicity of MPTP relies on the entry of MPP + into dopaminergic neurons through the plasma membrane dopamine transporter and, once inside dopaminergic neurons, on the accumulation of MPP + within mitochondrial matrix by a mechanism that depends on mitochondrial membrane potential (Ácm) (Przedborski et al., 2004) . Although we cannot completely rule out that POLG D257A mice may have a functional deficit in the dopamine uptake system, these animals do not exhibit any defects in the maintenance in mitochondrial Ácm, indicating that the process of accumulation of MPP + within mitochondria may not be affected. Supporting the latter, MPP + inhibited in a similar manner complex I-driven mitochondrial respiration in isolated brain mitochondria from either POLG D257A and wild-type mice. Our study indicates that primary accumulation of high levels of mitochondrial DNA deletions (up to 60%, as observed in patients with Parkinson's disease and aged individuals) is not sufficient per se to kill substantia nigra pars compacta dopaminergic neurons. Similar to our results, no cell death or mitochondrial defects linked to accumulation of mitochondrial DNA alterations had been previously observed in transgenic mice expressing neuron-specific or heart-specific mutant POLG forms (Zhang et al., 2000; Mott et al., 2001; Zhang et al., 2003; Kubota et al., 2006) . In contrast, other studies have shown that partial depletion of mitochondrial DNA in mice, either by a conditional disruption in dopaminergic neurons of mitochondrial transcription factor A (TFAM), which regulates mitochondrial DNA transcription (Ekstrand et al., 2007) , or by expression of a mitochondria-targeted restriction enzyme (PstI), which induces double-strand breaks in mitochondrial DNA (Pickrell et al., 2011) , leads to respiratory chain defects and slowly progressive, levodopa-responsive motor deficits associated with nigrostriatal denervation. These results suggest that mitochondrial DNA depletions, rather than deletions, could potentially contribute to Parkinson's disease-linked dopaminergic neurodegeneration. However, no mitochondrial DNA depletions have been detected so far in samples from patients with Parkinson's disease.
The compensatory mitochondrial effects reported here in POLG D257A mice may prove beneficial only below a certain threshold of mitochondrial DNA deletions, as cells with mitochondrial DNA deletions exceeding 60% of total mitochondrial DNA started to exhibit mitochondrial biochemical defects, such as decreased COX activity. COX-negative cells, however, were quite rare in the substantia nigra pars compacta of POLG D257A mice thus indicating that most substantia nigra pars compacta dopaminergic neurons did not actually reach mitochondrial DNA deletion levels 460% despite possessing proofreading-deficient forms of POLG. Because these animals exhibit reduced lifespan with premature death at 13 months of age, it remains unknown, however, whether mitochondrial DNA deletions would reach higher levels if these animals had lived longer. Remarkably, the levels of mitochondrial DNA deletions observed in the substantia nigra pars compacta of POLG D257A mice ($40-60%) are very similar to the ones previously reported in the substantia nigra pars compacta of patients with Parkinson's disease and aged individuals (Bender et al., 2006) . Because post-mortem tissue from patients with Parkinson's disease usually represents late stages of the disease, one can hypothesize that substantia nigra pars compacta dopaminergic cells still present in late-stage disease may be those accumulating fewer mitochondrial DNA deletions (560%) whereas neurons that have already been lost in these brains might have had higher levels (460%) of mitochondrial DNA deletions. Supporting this possibility, a recent study reported higher levels of somatic mitochondrial DNA point mutations in nigral neurons from early-stage Parkinson's disease cases and cases with incidental Lewy body disease, which may represent an early presymptomatic stage of Parkinson's disease, compared with late-stage Parkinson's disease cases or controls (Lin et al., 2012) . The lack of a pathogenic effect of mitochondrial DNA deletions below a threshold as high as 60% in substantia nigra pars compacta dopaminergic neurons of POLG D257A mice can be potentially explained by the observed mitochondrial compensatory mechanisms occurring in these animals, such as increased levels of OPA1, enhancement of mitochondrial cristae network or decreased production of mitochondrial-derived reactive oxygen species. Indeed, we have previously shown that mitochondrial reactive oxygen species production is pivotal in setting the threshold for mitochondriadependent dopaminergic neurodegeneration, as overexpression of mitochondrially-targeted catalase (an antioxidant enzyme normally localized in the peroxisome) in transgenic mice results in an attenuation of MPTP-induced mitochondrial reactive oxygen species and reduced dopaminergic cell death in a gene dosage-dependent manner (Perier et al., 2010) . Also, viral vector-mediated overexpression of OPA1 in the substantia nigra of mice was shown to protect dopaminergic neurons against MPTP neurotoxicity by keeping mitochondrial cristae junctions tight and thus preventing pro-apoptotic remodelling of mitochondria ultrastructure (Ramonet et al., 2013) . Overall, the results presented here indicate that levels of mitochondrial DNA deletions up to a certain threshold, as observed in patients with Parkinson's disease and aged individuals, do not kill dopaminergic neurons but trigger instead neuroprotective mitochondrial compensatory mechanisms that allow for maintenance of the function and integrity of the nigrostriatal system despite a high load of mitochondrial DNA deletions. This observation may have important implications for our understanding of the pathogenesis of Parkinson's disease, as similar compensatory mechanisms may eventually account for the preservation of dopaminergic function at early stages of the Parkinson's disease process and could thus be explored as a potential therapeutic target to delay the progression of dopamine dysfunction in Parkinson's disease.
